학술논문

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
Document Type
article
Author
Li, ShuaiSilvestri, ValentinaLeslie, GoskaRebbeck, Timothy RNeuhausen, Susan LHopper, John LNielsen, Henriette RoedLee, AndrewYang, XinMcGuffog, LesleyParsons, Michael TAndrulis, Irene LArnold, NorbertBelotti, MurielBorg, ÅkeBuecher, BrunoBuys, Saundra SCaputo, Sandrine MChung, Wendy KColas, ChrystelleColonna, Sarah VCook, JackieDaly, Mary Bde la Hoya, Miguelde Pauw, AntoineDelhomelle, HélèneEason, JacquelineEngel, ChristophEvans, D GarethFaust, UlrikeFehm, Tanja NFostira, FlorentiaFountzilas, GeorgeFrone, MeganGarcia-Barberan, VanesaGarre, PilarGauthier-Villars, MarionGehrig, AndreaGlendon, GordGoldgar, David EGolmard, LisaGreene, Mark HHahnen, EricHamann, UteHanson, HelenHassan, TiaraHentschel, JuliaHorvath, JuditIzatt, LouiseJanavicius, RamunasJiao, YueJohn, Esther MKarlan, Beth YKim, Sung-WonKonstantopoulou, IreneKwong, AvaLaugé, AnthonyLee, Jong WonLesueur, FabienneMebirouk, NouraMeindl, AlfonsMouret-Fourme, EmmanuelleMusgrave, HannahYie, Joanne Ngeow YuenNiederacher, DieterPark, Sue KPedersen, Inge SokildeRamser, JulianeRamus, Susan JRantala, JohannaRashid, Muhammad UReichl, FlorianRitter, JuliaRump, AndreasSantamariña, MartaSaule, ClaireSchmidt, GunnarSchmutzler, Rita KSenter, LeighaShariff, SabaSinger, Christian FSouthey, Melissa CStoppa-Lyonnet, DominiqueSutter, ChristianTan, YenTeo, Soo HwangTerry, Mary BethThomassen, MadsTischkowitz, MarcToland, Amanda ETorres, DianaVega, AnaWagner, Sebastian AWang-Gohrke, ShanWappenschmidt, BarbaraWeber, Bernhard HFYannoukakos, DrakoulisSpurdle, Amanda BEaston, Douglas FChenevix-Trench, Georgia
Source
Journal of Clinical Oncology. 40(14)
Subject
Ovarian Cancer
Cancer
Urologic Diseases
Breast Cancer
Prevention
Digestive Diseases
Aging
Rare Diseases
Aetiology
2.1 Biological and endogenous factors
BRCA1 Protein
BRCA2 Protein
Breast Neoplasms
Breast Neoplasms
Male
Female
Genetic Predisposition to Disease
Heterozygote
Humans
Infant
Newborn
Male
Mutation
Ovarian Neoplasms
Pancreatic Neoplasms
Risk
Clinical Sciences
Oncology and Carcinogenesis
Oncology & Carcinogenesis
Language
Abstract
PurposeTo provide precise age-specific risk estimates of cancers other than female breast and ovarian cancers associated with pathogenic variants (PVs) in BRCA1 and BRCA2 for effective cancer risk management.MethodsWe used data from 3,184 BRCA1 and 2,157 BRCA2 families in the Consortium of Investigators of Modifiers of BRCA1/2 to estimate age-specific relative (RR) and absolute risks for 22 first primary cancer types adjusting for family ascertainment.ResultsBRCA1 PVs were associated with risks of male breast (RR = 4.30; 95% CI, 1.09 to 16.96), pancreatic (RR = 2.36; 95% CI, 1.51 to 3.68), and stomach (RR = 2.17; 95% CI, 1.25 to 3.77) cancers. Associations with colorectal and gallbladder cancers were also suggested. BRCA2 PVs were associated with risks of male breast (RR = 44.0; 95% CI, 21.3 to 90.9), stomach (RR = 3.69; 95% CI, 2.40 to 5.67), pancreatic (RR = 3.34; 95% CI, 2.21 to 5.06), and prostate (RR = 2.22; 95% CI, 1.63 to 3.03) cancers. The stomach cancer RR was higher for females than males (6.89 v 2.76; P = .04). The absolute risks to age 80 years ranged from 0.4% for male breast cancer to approximately 2.5% for pancreatic cancer for BRCA1 carriers and from approximately 2.5% for pancreatic cancer to 27% for prostate cancer for BRCA2 carriers.ConclusionIn addition to female breast and ovarian cancers, BRCA1 and BRCA2 PVs are associated with increased risks of male breast, pancreatic, stomach, and prostate (only BRCA2 PVs) cancers, but not with the risks of other previously suggested cancers. The estimated age-specific risks will refine cancer risk management in men and women with BRCA1/2 PVs.